Renal failure treatment is not a single solution. It is a carefully coordinated plan designed around how much kidney function remains, what caused the damage, and what a patient’s overall health looks like.
Here is what you need to know about your options:
- Treatment targets the root cause. Renal failure treatment focuses on slowing damage, managing complications, and preserving remaining kidney function for as long as possible.
- Multiple treatment paths exist. Depending on the stage of kidney failure, options range from medications and dietary changes to dialysis and kidney transplant.
- Early specialist care makes a difference. Connecting with a nephrologist early — before reaching end-stage kidney disease — gives patients more options and better long-term outcomes.
Renal failure treatment begins the moment a nephrologist confirms that the kidneys can no longer filter waste, balance fluids, and regulate blood pressure on their own. That moment can feel overwhelming. But understanding what treatment actually involves — and why each step matters — can make the process far less daunting.
According to the American Kidney Fund, approximately 815,000 Americans are currently living with kidney failure, and roughly 555,000 of them are on dialysis. Yet 9 out of 10 people with kidney disease do not know they have it until the condition has already progressed significantly. That gap between diagnosis and early intervention is exactly where specialized nephrology care can change outcomes.
This guide breaks down how renal failure treatment works, what the main options are, what the latest research says, and how to find trusted renal failure treatment near you in southeastern Massachusetts.
What Is Renal Failure, and When Does Treatment Begin?
Renal failure — also called kidney failure or end-stage kidney disease (ESKD) — occurs when the kidneys lose approximately 85% to 90% of their normal function. The kidneys can no longer remove waste products, control fluid levels, or maintain the chemical balance the body depends on.
Treatment typically begins well before full kidney failure sets in. Nephrologists monitor kidney function through estimated glomerular filtration rate (eGFR) and urine tests that detect protein in the urine (albuminuria). When results show declining kidney function, a structured treatment plan begins — even at earlier stages of chronic kidney disease (CKD).
The Centers for Disease Control and Prevention notes that kidney disease affects more than 1 in 7 American adults, with diabetes and high blood pressure identified as the two leading causes. Diabetes alone accounts for about 45% of new kidney failure cases each year.
What Does Renal Failure Treatment Actually Do for Your Kidneys?
Renal failure treatment does not repair damaged kidney tissue. Instead, it works to slow the rate of further damage, manage the complications that arise when kidneys stop working properly, and — in the case of dialysis or transplant — take over the filtering work the kidneys can no longer do.
The goals of treatment shift depending on the stage of disease. In early and moderate stages, the focus is on protecting remaining function. In the later stages, treatment shifts toward replacing kidney function entirely.
Treating complications is just as important as treating the kidneys themselves. When kidneys fail, patients often develop anemia, high blood pressure, fluid retention, weakened bones, and dangerous changes in blood potassium and acid levels. Each of these complications has its own targeted treatment.
What Are the Main Types of Renal Failure Treatment?
There are several evidence-based approaches to renal failure treatment, and most patients use more than one at the same time. A nephrologist will build a treatment plan based on the underlying cause, stage of kidney disease, and other health conditions.
Medications That Help Slow Kidney Damage
Certain medications are proven to slow the progression of kidney disease. According to Mayo Clinic, the most commonly used include:
- ACE inhibitors and ARBs — angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) lower blood pressure and reduce stress on the kidney filters.
- SGLT2 inhibitors — originally developed for type 2 diabetes, sodium-glucose cotransporter-2 (SGLT2) inhibitors like empagliflozin (Jardiance) and dapagliflozin (Farxiga) have shown strong kidney-protective effects even in patients without diabetes.
- Statins — used to reduce cholesterol and lower the risk of heart disease, which is a major complication in kidney failure patients.
- Erythropoiesis-stimulating agents — hormone injections to stimulate red blood cell production and treat anemia caused by kidney failure.
- Phosphate binders — taken with meals to reduce the amount of phosphate absorbed from food, protecting blood vessels and bones.
Dialysis: Hemodialysis and Peritoneal Options
When kidney function drops too low to sustain life, dialysis takes over the work of filtering blood. There are two main types:
- Hemodialysis filters blood through an external machine. Most patients attend a dialysis center three times per week, with each session lasting approximately three to four hours. Some patients qualify for home hemodialysis with proper training and support.
- Peritoneal dialysis uses the lining of the abdomen as a natural filter. A thin tube is surgically placed in the abdomen, and a cleansing fluid (dialysate) is introduced, absorbs waste, and is drained after a set period. Most patients perform this at home, often overnight, using a machine called a cycler.
Both forms of dialysis have benefits and drawbacks that depend on a patient’s lifestyle, health status, and proximity to a dialysis center. A nephrologist can help determine which approach fits best.
Kidney Transplant: The Best Long-Term Option?
A kidney transplant is widely considered the most effective long-term renal failure treatment for eligible patients. A healthy kidney from a living or deceased donor is surgically placed in the lower abdomen, and the patient takes anti-rejection medications for the rest of their life to prevent the immune system from attacking the new organ.
Not everyone is a transplant candidate. A detailed evaluation assesses cardiovascular health, body weight, infection risk, and other factors before a patient is added to the waiting list. According to the American Kidney Fund, there are more than 90,000 Americans currently on the kidney transplant waiting list, but only 28,492 transplants were completed in 2024 — roughly 1 in 4 of those waiting.
Of the approximately 131,000 Americans newly diagnosed with kidney failure in 2022, nearly 97% began dialysis, while only 4,524 received a preemptive kidney transplant before needing dialysis at all.
What New Renal Failure Treatments Are Changing the Field?
The landscape of renal failure treatment is expanding rapidly, with several significant developments emerging from recent clinical trials and regulatory approvals.
A study published in the New England Journal of Medicine in February 2025 — the EMPA-KIDNEY trial — followed 6,609 patients with chronic kidney disease over a combined active and post-trial period of approximately four years. The trial found that empagliflozin (Jardiance), an SGLT2 inhibitor, reduced the risk of kidney disease progression from 27.1% in the placebo group to 23.5% in the treatment group.
The risk of death or end-stage kidney disease also dropped, from 19.6% to 16.9%. Notably, these protective effects continued for up to 12 months after the medication was discontinued — a finding that has significant implications for long-term treatment planning.
A 2025 Global Burden of Disease analysis published in The Lancet Global Health found that kidney failure with replacement therapy affects approximately 5 million people globally, with the prevalence of the two leading causes — type 2 diabetes and high blood pressure — continuing to rise. The study emphasized the urgent need for cost-effective prevention strategies, particularly in lower-resource settings.
On the medication front, the National Kidney Foundation reported six new kidney disease medications approved by the U.S. Food and Drug Administration (FDA) in 2025 alone:
- Ozempic (semaglutide) — a GLP-1 receptor agonist approved in 2025 to slow kidney disease progression and reduce the risk of kidney failure in adults with both type 2 diabetes and CKD
- Voyxact (sibeprenlimab-szsi) — a monoclonal antibody approved for IgA nephropathy (IgAN) that blocks the protein APRIL, which triggers abnormal IgA buildup in the kidneys
- Fabhalta (iptacopan) — a complement inhibitor approved for complement 3 glomerulopathy (C3G), a rare immune-related kidney disease
- Empaveli (pegcetacoplan) — approved for C3G and primary immune complex membranoproliferative glomerulonephritis (IC-MPGN) in patients ages 12 and older
- Vanrafia (atrasentan) — an endothelin receptor antagonist approved for IgAN that reduces pressure and scarring inside the kidneys
- Gazyva (obinutuzumab) — an IV-administered monoclonal antibody approved for active lupus nephritis alongside standard treatment
These approvals represent a significant shift from one-size-fits-all renal failure treatment toward precision therapies that target the specific biological mechanisms driving kidney damage in each patient.
What Lifestyle Changes Support Your Treatment Plan?
Medications and procedures work best when paired with consistent lifestyle modifications. A nephrologist will typically recommend the following dietary and behavioral changes as part of any renal failure treatment plan:
- Reduce sodium intake — aim for no more than 2,000 milligrams of sodium per day
- Limit potassium and phosphorus — high-potassium foods like bananas, tomatoes, and potatoes can be dangerous when kidneys cannot filter them
- Lower protein consumption — reducing protein intake decreases the waste load on the kidneys
- Manage blood pressure daily — home blood pressure monitoring, combined with prescribed medications, supports kidney protection
- Stay physically active — regular, moderate exercise supports cardiovascular health, which is closely linked to kidney function
- Avoid nephrotoxic substances — nonsteroidal anti-inflammatory drugs (NSAIDs), certain herbal supplements, and contrast dyes used in some imaging tests can accelerate kidney damage
These changes are not optional add-ons. They are active components of renal failure treatment that directly affect how quickly kidney function declines.
Frequently Asked Questions (FAQ)
To help you and your family understand your options for managing kidney health, here are our most frequently asked questions regarding our renal failure treatment near you.
What is the most effective renal failure treatment available today?
Kidney transplant is considered the most effective long-term renal failure treatment for eligible patients, offering the best quality of life and survival outcomes. For patients who are not transplant candidates, dialysis combined with targeted medications and lifestyle management remains the standard of care.
The right option depends on the patient’s stage of disease, overall health, and personal circumstances.
Can renal failure be reversed with treatment?
Renal failure caused by chronic kidney disease cannot be reversed. However, early and consistent renal failure treatment can slow progression significantly, preserve remaining kidney function, and delay or prevent the need for dialysis or transplant.
Acute kidney injury — a sudden, short-term loss of function — can sometimes be reversed with prompt treatment of the underlying cause.
What are the warning signs that someone needs renal failure treatment?
Kidney disease often has no symptoms in its early stages. When symptoms do appear, they may include swelling in the legs and ankles, fatigue, changes in urination (more or less frequent, foamy, or discolored urine), shortness of breath, nausea, and difficulty concentrating.
Anyone with diabetes, high blood pressure, or a family history of kidney disease should be tested regularly.
How often do patients receiving hemodialysis need to attend treatment sessions?
Most patients receiving in-center hemodialysis attend three sessions per week, each lasting approximately three to four hours. Home hemodialysis schedules vary depending on the prescription — some patients do shorter sessions more frequently, which may better mimic natural kidney function.
A nephrologist and dialysis care team will determine the schedule based on lab values and individual needs.
What should I ask when looking for renal failure treatment near me?
When searching for renal failure treatment near you, ask whether the practice specializes in nephrology, whether they coordinate dialysis access and transplant referrals, and whether they work closely with dietitians and other specialists.
Also ask about wait times for appointments, availability of telehealth for follow-up visits, and whether the practice accepts your insurance.
How Do You Find Renal Failure Treatment Near SE Massachusetts?
Finding the right provider for renal failure treatment near you starts with identifying a board-certified nephrologist — a physician who specializes exclusively in kidney disease. Primary care physicians can treat early-stage CKD, but once kidney function drops below a certain threshold or complications arise, specialized nephrology care is essential.
For patients in southeastern Massachusetts, Associates in Nephrology provides expert kidney care across two convenient locations in Brockton and Taunton. Our practice specializes in diagnosing and managing kidney disease at every stage with a patient-focused approach built around protecting kidney function and quality of life.
Do not wait for symptoms to appear. Kidney disease is often silent until it has already progressed significantly. A referral to a nephrologist or a direct inquiry to Associates in Nephrology, PC, can be the step that changes your trajectory.
Call Associates in Nephrology at (508) 587-0700 or use our online appointment request form to schedule a consultation at our Brockton or Taunton, MA, locations today.
